Erectile Dysfunction Therapeutics Market Pipeline Review, H2
2017
“Pharmaceutical and Healthcare disease pipeline guide Erectile Dysfunction
- Pipeline Review, H2 2017, provides an overview of the Erectile Dysfunction
(Male Health) pipeline landscape.”
Summary
Pharmaceutical and Healthcare disease pipeline guide Erectile Dysfunction - Pipeline Review, H2 2017,
provides an overview of the Erectile Dysfunction (Male Health) pipeline landscape.
Erectile dysfunction, or ED, is the inability of a man to have an erection hard enough to have sexual
intercourse. It can also be known as impotence. The predisposing factors include tobacco usage, overweight,
injuries, drug and alcohol use and medications, including antidepressants, antihistamines and medications to
treat high blood pressure, pain or prostate cancer.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Erectile Dysfunction - Pipeline Review, H2 2017, provides
comprehensive information on the therapeutics under development for Erectile Dysfunction (Male Health),
complete with analysis by stage of development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest news and press releases.
Browse Detail Report With TOC @
http://www.hexareports.com/report/erectile-dysfunction-pipeline-review-h2-2017
Follow Us: